Skip to main content
. 2022 Jul 26;13:4334. doi: 10.1038/s41467-022-32092-8

Fig. 2. Vβ8-CAR-T cells specifically targeted Vβ8+ T cell leukemia cells in vitro.

Fig. 2

a Untransduced T cells or Vβ8-CAR-T cells were cocultured with Lenti-X 293-Vβ8- or Lenti-X 293-Vβ8+ cells in triplicate wells at a CAR-T:Lenti-X 293 cell ratio of 2:1 for 24 h (n = 3 biologically independent samples/group). The indicated cytokines in the supernatants were analyzed by performing a CBA assay. The data shown represent the mean ± SEM. Statistical significance was determined by two-sided, two-way ANOVA with Sidaks multiple comparisons test. be Untransduced T cells or Vβ8-CAR-T cells were cocultured with Jurkat-Vβ8- or Jurkat-Vβ8+ cells in triplicate wells at a CAR-T: Jurkat cell ratio of 1:2 for 24 h (n = 3 biologically independent samples/group). Cytotoxicity was determined by analyzing the remaining IRFP+ cells with flow cytometry (b). The indicated cytokines in the supernatants were analyzed by performing CBA assays (c). Granzyme B (d) and active caspase-3 (e) were analyzed by flow cytometry. The data shown represent the mean ± SEM. Statistical significance was determined by two-sided unpaired t-tests. The normality of the data was confirmed by the Shapiro–Wilk test.